Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-12-20 4:32 pm Sale | 13G | UNICYCIVE THERAPEUTICS INC UNCY | Nantahala Capital Management LLC | 0 0.000% | -3,475,713 (Position Closed) | View |
| 2024-11-06 4:31 pm Purchase | 13D | Evoke Pharma Inc EVOK | Nantahala Capital Management LLC | 254,632 15.990% | 169,946 (+200.68%) | View |
| 2024-11-05 4:32 pm Purchase | 13G | EAGLE PHARMACEUTICALS INC EGRX | Nantahala Capital Management LLC | 3,945,209 30.400% | 1,983,139 (+101.07%) | View |
| 2024-10-01 4:53 pm Unchanged | 13D | Evoke Pharma Inc EVOK | Nantahala Capital Management LLC | 84,686 10.000% | 0 (Unchanged) | View |
| 2024-09-24 4:31 pm Purchase | 13D | AMERICAS CARMART INC CRMT | Nantahala Capital Management LLC | 544,686 6.700% | 544,686 (New Position) | View |
| 2024-09-20 7:28 pm Purchase | 13D | Evoke Pharma Inc EVOK | Nantahala Capital Management LLC | 84,686 10.000% | 84,686 (New Position) | View |
| 2024-08-30 4:32 pm Sale | 13G | RumbleOn Inc. RMBL | Nantahala Capital Management LLC | 3,066,537 8.700% | -1,349,969 (-30.57%) | View |
| 2024-07-03 2:02 pm Purchase | 13G | EAGLE PHARMACEUTICALS INC EGRX | Nantahala Capital Management LLC | 1,962,070 15.100% | 1,962,070 (New Position) | View |
| 2024-06-18 4:30 pm Unchanged | 13D | AYTU BIOPHARMA INC PAR $0. AYTU | Nantahala Capital Management LLC | 1,086,812 18.200% | 0 (Unchanged) | View |
| 2024-03-11 4:06 pm Purchase | 13G | Rezolute Inc. RZLT | Nantahala Capital Management LLC | 4,118,164 9.900% | 4,118,164 (New Position) | View |
| 2024-02-14 4:51 pm Sale | 13G | RMR GROUP INC RMR | Nantahala Capital Management LLC | 404,063 2.600% | -554,211 (-57.83%) | View |
| 2024-02-14 4:51 pm Sale | 13G | VIEMED HEALTHCARE IN VMD | Nantahala Capital Management LLC | 1,952,368 5.100% | -845,220 (-30.21%) | View |
| 2024-02-14 4:51 pm Sale | 13G | Cidara Therapeutics Inc. CDTX | Nantahala Capital Management LLC | 1,546,745 1.700% | -2,820,719 (-64.58%) | View |
| 2024-02-14 4:51 pm Sale | 13G | FORTRESS BIOTECH INC FBIO | Nantahala Capital Management LLC | 372,562 4.200% | -7,595,494 (-95.32%) | View |
| 2024-02-14 4:51 pm Sale | 13G | IMAX CORP IMAX | Nantahala Capital Management LLC | 2,658,753 4.900% | -2,329,436 (-46.70%) | View |
| 2024-02-14 4:51 pm Unchanged | 13G | SPYRE THERAPEUTICS, INC SYRE | Nantahala Capital Management LLC | 0 0.000% | 0 (Unchanged) | View |
| 2024-02-14 4:51 pm Purchase | 13G | BIOVENTUS INC BVS | Nantahala Capital Management LLC | 5,977,471 9.500% | 5,977,471 (New Position) | View |
| 2024-02-14 4:51 pm Purchase | 13G | CODEXIS INC CDXS | Nantahala Capital Management LLC | 4,592,903 6.600% | 105,121 (+2.34%) | View |
| 2024-02-14 4:51 pm Sale | 13G | DHI GROUP INC. DHX | Nantahala Capital Management LLC | 2,639,687 5.600% | -1,022,289 (-27.92%) | View |
| 2024-02-14 4:51 pm Sale | 13G | LUXFER HOLDINGS PLC SHS LXFR | Nantahala Capital Management LLC | 1,809,645 6.700% | -642,674 (-26.21%) | View |